Benzinga's Top Initiations

Loading...
Loading...
Analysts at SunTrust Robinson Humphrey initiated coverage on
Bellerophon Therapeutics LLCBLPH
with a Buy rating. The target price for Bellerophon Therapeutics is set to $23. Bellerophon Therapeutics' shares closed at $9.75 on Friday. Analysts at Sterne Agee initiated coverage on
Hanesbrands Inc.HBI
with a Buy rating. The target price for Hanesbrands is set to $38. Hanesbrands' shares closed at $32.61 on Friday. Nomura initiated coverage on
Inotek Pharmaceuticals CorporationITEK
with a Buy rating. The target price for Inotek Pharmaceuticals is set to $13. Inotek Pharmaceuticals' shares closed at $5.69 on Friday. Analysts at UBS initiated coverage on
American Midstream Partners, LPAMID
with a Neutral rating. The target price for American Midstream is set to $18. American Midstream's shares closed at $17.52 on Friday.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsTop Initiations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...